Company performance
Add to research
Current Price
as of Mar 21, 2025$70.46
P/E Ratio
30.35
Market Cap
$41.42B
Description
Add to research
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Metrics
Add to research
Overview
- HQIrvine, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerEW
- Price$70.46-0.69%
Trading Information
- Market cap$41.42B
- Float98.05%
- Average Daily Volume (1m)4,864,839
- Average Daily Volume (3m)4,463,418
- EPS$2.34
Company
- Revenue$5.44B
- Rev growth (1yr)-9.41%
- Net income$1.40B
- Gross margin78.80%
- EBITDA margin29.41%
- EBITDA$1.60B
- EV$41.15B
- EV/Revenue7.57
- P/E30.35
- P/S7.82
- P/B4.18
- Debt/Equity7.00
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account
StreetAccount Metrics Recap - Edwards Lifesciences Q3 Earnings ($68.34, 0.00) (2023-10-25T20:22:05Z)
Factset